Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial
Yimei Feng(Xinqiao Hospital), Xi Zhang(Army Medical University), Jianchuan Deng(Dalian Medical University), Lidan Zhu(Army Medical University), Hongyun Xing(Chongqing University), Jia Liu(Army Medical University), Ting Chen(Nanchang University), Linhui Wang(Second Military Medical University), Yuqing Liu(Central South University), Liangliang Ma(Dalian Medical University), Han Yao(Army Medical University), Mingqiang Ren(Zunyi Medical University), Tao Lang(People's Hospital of Xinjiang Uygur Autonomous Region), Lei Gao(Zhejiang Chinese Medical University), Hai Yi(Southwest Jiaotong University), Dan Wang(Wuhan University), Shichun Gao(Army Medical University)
Cited by 2
Related Papers
Recent advances in CAR-T cell engineering
|Journal of Hematology & Oncology|2020|403
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
|Frontiers in Oncology|2019|115
Strategies to enhance CAR-T persistence
|Biomarker Research|2022|90
Characteristics of acute myeloid leukemia with myelodysplasia‐related changes: A retrospective analysis in a cohort of <scp>Chinese</scp> patients
|American Journal of Hematology|2014|56